Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

share with twitter share with LinkedIn share with facebook
04/03/2020 | 05:15am EDT

DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052
Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

03.04.2020 / 10:10
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


- Share buy-back - 42nd Interim Report and Final Report

In the period from March 30, 2020 until and including April 1, 2020, a total of 1,906,796 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange and via selected multilateral trading facilities (MTF):

XETRA

Day of repurchase Aggregated volume in number of shares Weighted average share price
in EUR
30.03.2020 507,449 58.1217
31.03.2020 498,159 59.7579
01.04.2020 538,530 59.3516
 

Chi-X Europe

Day of repurchase Aggregated volume in number of shares Weighted average share price
in EUR
30.03.2020 78,533 58.1681
31.03.2020 71,899 59.7985
01.04.2020 99,953 59.3799
 

BATS Europe

Day of repurchase Aggregated volume in number of shares Weighted average share price
in EUR
30.03.2020 11,516 58.2242
31.03.2020 19,031 59.7440
01.04.2020 31,370 59.4862
 


Turquoise

Day of repurchase Aggregated volume in number of shares Weighted average share price
in EUR
30.03.2020 13,694 58.0568
31.03.2020 11,702 59.6980
01.04.2020 24,960 59.2190
 

The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including April 1, 2020 therefore amounts to 10,795,151 shares. The weighted average share price paid for these shares amounted to EUR 61.0270. This concludes the share buy-back programme.

Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., April 3, 2020



03.04.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com

 
End of News DGAP News Service

1014831  03.04.2020 

fncls.ssp?fn=show_t_gif&application_id=1014831&application_name=news&site_id=zonebourse
© EQS 2020

share with twitter share with LinkedIn share with facebook
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
05:24aFMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan gives a Buy rating
MD
04:44aFRESENIUS SE : Buy rating from JP Morgan
MD
04:25aFMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from Goldman Sachs
MD
03:00aFMC FRESENIUS MEDICAL CARE AG & CO K : Berenberg gives a Buy rating
MD
10/23FRESENIUS SE : Receives a Buy rating from Goldman Sachs
MD
10/23FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from Goldman Sachs
MD
10/22FRESENIUS SE : Credit Suisse reiterates its Neutral rating
MD
10/22FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse reaffirms its Neutral ratin..
MD
10/22FMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse remains Neutral
MD
10/21FRESENIUS SE : Berenberg reiterates its Buy rating
MD
More news
Financials (USD)
Sales 2020 21 511 M - -
Net income 2020 1 549 M - -
Net Debt 2020 14 311 M - -
P/E ratio 2020 15,3x
Yield 2020 1,75%
Capitalization 23 755 M 23 774 M -
EV / Sales 2020 1,77x
EV / Sales 2021 1,65x
Nbr of Employees 124 736
Free-Float 65,1%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 97,67 $
Last Close Price 81,12 $
Spread / Highest target 41,5%
Spread / Average Target 20,4%
Spread / Lowest Target -21,6%
EPS Revisions
Managers
NameTitle
Rice Powell Chairman-Management Board
Dieter Schenk Chairman-Supervisory Board
Helen Giza Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer